Industry5h ago
AI Cuts Drug Research Costs By 70%
Early-stage pharmaceutical research costs and timelines have dropped by up to 70% through AI integration. These tools accelerate the identification of viable drug candidates before human trials begin. International Business Times reports this shift as a major efficiency gain. Practitioners can now iterate on molecular designs faster, reducing the financial risk of early-phase failure.